6 December 2011, Lysaker, Norway: CEO Morten Jurs gave a presentation of Pronova BioPharma at DNB Markets and Sigma Fondsforvaltning Annual Health Care Conference. The presentation was held in Oslo, Norway.
The presentation is attached and is also available on http://www.pronova.com.
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)
DNB Markets annual health care conference (http://hugin.info/137506/R/1568922/487636.pdf)
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
HUG#1568922